DE602006003883D1 - Verfahren zur herstellung von alphaformkristallen von sapropterinhydrochlorid - Google Patents

Verfahren zur herstellung von alphaformkristallen von sapropterinhydrochlorid

Info

Publication number
DE602006003883D1
DE602006003883D1 DE602006003883T DE602006003883T DE602006003883D1 DE 602006003883 D1 DE602006003883 D1 DE 602006003883D1 DE 602006003883 T DE602006003883 T DE 602006003883T DE 602006003883 T DE602006003883 T DE 602006003883T DE 602006003883 D1 DE602006003883 D1 DE 602006003883D1
Authority
DE
Germany
Prior art keywords
crystals
degrees
sapropterinhydrochloride
alphaformry
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006003883T
Other languages
English (en)
Inventor
Katsumi Hotoda
Hiroomi Kiyono
Shinnosuke Tazawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiratori Pharmaceutical Co Ltd
Daiichi Sankyo Co Ltd
Original Assignee
Shiratori Pharmaceutical Co Ltd
Daiichi Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiratori Pharmaceutical Co Ltd, Daiichi Asubio Pharma Co Ltd filed Critical Shiratori Pharmaceutical Co Ltd
Publication of DE602006003883D1 publication Critical patent/DE602006003883D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
DE602006003883T 2005-04-14 2006-04-13 Verfahren zur herstellung von alphaformkristallen von sapropterinhydrochlorid Active DE602006003883D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005116687 2005-04-14
PCT/JP2006/308264 WO2006112495A1 (en) 2005-04-14 2006-04-13 Method for producing alpha form crystals of sapropterin hydrochloride

Publications (1)

Publication Number Publication Date
DE602006003883D1 true DE602006003883D1 (de) 2009-01-08

Family

ID=36617398

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006003883T Active DE602006003883D1 (de) 2005-04-14 2006-04-13 Verfahren zur herstellung von alphaformkristallen von sapropterinhydrochlorid

Country Status (15)

Country Link
US (1) US8039617B2 (de)
EP (1) EP1869048B8 (de)
JP (1) JP4980230B2 (de)
KR (1) KR101258430B1 (de)
CN (1) CN101160310B (de)
AT (1) ATE415403T1 (de)
AU (1) AU2006237936B2 (de)
BR (1) BRPI0608863B1 (de)
CA (1) CA2604818C (de)
DE (1) DE602006003883D1 (de)
DK (1) DK1869048T3 (de)
ES (1) ES2317529T3 (de)
PL (1) PL1869048T3 (de)
PT (1) PT1869048E (de)
WO (1) WO2006112495A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009088979A1 (en) 2008-01-07 2009-07-16 Biomarin Pharmaceutical Inc. Method of synthesizing tetrahydrobiopterin
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
CN108033963A (zh) * 2017-12-29 2018-05-15 天津凯莱英制药有限公司 沙丙喋呤二盐酸盐晶型b及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60178887A (ja) * 1984-02-23 1985-09-12 Kanegafuchi Chem Ind Co Ltd 5,6,7,8−テトラヒドロ−l−ビオプテリンの製造法
JPS61172876A (ja) * 1985-01-28 1986-08-04 Shiratori Seiyaku Kk (6r)−テトラヒドロ−l−バイオプテリンの製造法
US4713454A (en) * 1985-01-28 1987-12-15 Shiratori Pharmaceutical Co., Ltd. Preparation process of (6R)-tetrahydro-L-biopterin
JP2711828B2 (ja) 1996-06-25 1998-02-10 白鳥製薬株式会社 (6r)−テトラヒドローl−バイオプテリン塩酸塩の製造法
ES2755334T3 (es) * 2003-11-17 2020-04-22 Merck & Cie Proceso para la preparación de formas cristalinas B de clorhidrato de (6R)-L-eritro-tetrahidrobiopterina a partir de otras formas cristalinas

Also Published As

Publication number Publication date
WO2006112495A1 (en) 2006-10-26
CN101160310B (zh) 2010-05-26
ES2317529T3 (es) 2009-04-16
EP1869048B8 (de) 2009-04-15
EP1869048B1 (de) 2008-11-26
JP2008535770A (ja) 2008-09-04
KR20080000582A (ko) 2008-01-02
CN101160310A (zh) 2008-04-09
ATE415403T1 (de) 2008-12-15
BRPI0608863B1 (pt) 2022-09-27
PT1869048E (pt) 2009-03-05
AU2006237936B2 (en) 2011-06-16
EP1869048A1 (de) 2007-12-26
BRPI0608863A2 (pt) 2010-02-02
CA2604818A1 (en) 2006-10-26
JP4980230B2 (ja) 2012-07-18
DK1869048T3 (da) 2009-03-09
CA2604818C (en) 2012-12-04
US8039617B2 (en) 2011-10-18
AU2006237936A1 (en) 2006-10-26
KR101258430B1 (ko) 2013-04-26
PL1869048T3 (pl) 2009-05-29
US20090270619A1 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
ATE440690T1 (de) Gold nanopartikel und verfahren zur herstellung
ATE483044T1 (de) Verfahren zur herstellung von cellulosefaser
ATE487702T1 (de) Verfahren zum herstellen von 3-dihalomethyl- pyrazol-4-carbonsäurederivaten
DE502005002356D1 (de) Neue 2-benzylaminodihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE450488T1 (de) Lichtreaktives polymer und verfahren zu seiner herstellung
DE50307267D1 (de) Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
EA200801439A1 (ru) Способы производства частиц оксида титана, частицы и вещества, полученные этими способами
DE502004006603D1 (de) Verfahren zur herstellung von cyclododecanon
EA200701581A1 (ru) Способ получения циклогексанона и циклогексанола
ATE512990T1 (de) Verfahren zur herstellung von gereinigten beta-(1,3)-d-glucanen
JP2013502377A5 (de)
DE60326341D1 (de) Verfahren zur herstellung von anthranilsäurederivat-hydrat
GEP20135926B (en) Trazodone and trazodone hydrochloride in purified form
RU2013135276A (ru) Кристаллическая форма эртапенема натрия и способ ее получения
DE602006003883D1 (de) Verfahren zur herstellung von alphaformkristallen von sapropterinhydrochlorid
IL177286A0 (en) Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing same
ATE548446T1 (de) Herstellung und reinigung von protein a ohne die verwendung von tierischen komponenten
ATE414707T1 (de) Verfahren zur herstellung von 4-amino-4'-demethyl-4-desoxypodophylotoxin
BR112013023880A2 (pt) vidro plano e processo para produzir o mesmo
ATE478106T1 (de) Verfahren zur herstellung von polyarylat mit hoher wärmebeständigkeit und hoher transparenz
ATE423096T1 (de) Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten
DE502005009501D1 (de) Verfahren zur herstellung von candesartan
DE602005013007D1 (de) Verfahren zur herstellung von lactonen
TW200519974A (en) Dielectric-forming composition containing particles with perovskite crystal structure, production process and uses of the same, and process for preparing crystal particles having perovskite crystal structure
ATE444964T1 (de) 5-pyridinyl-1-azabicycloä3.2.1üoctan-derivate, herstellungsverfahren und deren verwendung für therapeutika

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ASUBIO PHARMA CO., LTD., TOKYO, JP

Owner name: SHIRATORI PHARMACEUTICAL CO. LTD., NARASHINO, , JP

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI SANKYO COMPANY, LIMITED, TOKIO, JP

Owner name: SHIRATORI PHARMACEUTICAL CO. LTD., NARASHINO, , JP